BridgeMD
Pragmatic clinical trial to assess the utility of SLCO1B1, ABCG2, and CYP2C9 preemtive genotyping and pharmacogenetics training on the incidence of musculoskeletal adverse reactions in patients treated with statins in primary and specialized care.
EU CTIS ID: 2023-506814-31-01
What this study is testing
The main objective is to evaluate the differences in the outcomes of musculoskeletal adverse reactions in a group of patients treated with statines according to clinical practice (control group) vs patients with a prescribed statin based on the prosprective genotyping of SLCO1B1, ABCG2 and CYP2C9 (intervention group), in a follow-up period of 6 months in patients treated from primary attention (healthcare centers) and hospitals ( Hospital de La Princesa).
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Adults, with any type of cardiovascular risk (high, moderate or low): a) In which it is indicated statins as a treatment at any dose. b) Pacients who must be outpatients, recruited in a health care centre (primary attention) or in hospitals (primary or secundary prevention). c) Pacients who must have never taken statins or who have started statin treatment less tan 15 days ago, or who had their statin dose increased or changed to a more potent statin due to bad control of LDL levels in the last 15 days. d) Patients who have to give their inform consent form written
You likely can't join if
- a) Pacients who statins are not prescribed as standard clinical practice. b) Pacients who suffer a malignant or terminal disease whose live expectancy will be less than 6 months. c) Pacients who have statins contraindicated for treatment d) Pregnant or breast-feeding patients.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.